EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

68 Ga radiolabeling strategies in Pt( iv )-deferoxamine scaffolds for potential theranostic application

Giulia Ferrari, Ines Lopez-Martinez, Mohamad Saqawa, Eithne Demspey, Thomas Wanek, Irena Pashkunova-Martic, Silvia Panseri, Marcus Hacker, Monica Montesi, Claudia Kuntner, Diego Montagner

Dalton Transactions · 2026

DOI: 10.1039/d5dt02352a ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dalton Transactions, 2026. Verfasst von Giulia Ferrari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Maynooth University, Maynooth, Ireland. diego.montagner@mu.ie. Hauptthemen laut MEDLINE: Deferoxamine, Gallium Radioisotopes, Theranostic Nanomedicine, Organoplatinum Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Science Foundation Ireland, HORIZON EUROPE Marie Sklodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of Pt( iv )-DFO (deferoxamine) complexes were successfully synthesised and radiolabelled with 68 Ga for potential theranostic applications in osteosarcoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeferoxamineGallium RadioisotopesTheranostic NanomedicineOrganoplatinum CompoundsPlatinumCoordination ComplexesPositron-Emission TomographyAnimalsHumansCell Line, TumorDogsTissue DistributionCell SurvivalAntineoplastic AgentsIsotope Labeling

Substanzen

DeferoxamineGallium RadioisotopesGallium-68Organoplatinum CompoundsPlatinumCoordination ComplexesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry, Maynooth University, Maynooth, Ireland. diego.montagner@mu.ie.
  • Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Preclinical Imaging Lab (PIL), Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria. claudia.kuntner@meduniwien.ac.at.
  • Institute of Science, Technology and Sustainability for Ceramics (ISSMC) - National Research Council (CNR), Faenza, RA, Italy. monica.montesi@issmc.cnr.it.
  • Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences, University of Messina, Messina, Italy.
  • Research Platform Medical Imaging (RPMI), Medical University of Vienna, Vienna, Austria.

Förderung

  • Science Foundation Ireland
  • HORIZON EUROPE Marie Sklodowska-Curie Actions

Zitieren

APA

Ferrari, G., Lopez-Martinez, I., Saqawa, M., Demspey, E., Wanek, T., Pashkunova-Martic, I., Panseri, S., Hacker, M., Montesi, M., Kuntner, C., & Montagner, D. (2026). 68 Ga radiolabeling strategies in Pt( iv )-deferoxamine scaffolds for potential theranostic application. Dalton Transactions. https://doi.org/10.1039/d5dt02352a

Vancouver

Ferrari G, Lopez-Martinez I, Saqawa M, Demspey E, Wanek T, Pashkunova-Martic I, et al. 68 Ga radiolabeling strategies in Pt( iv )-deferoxamine scaffolds for potential theranostic application. Dalton Transactions. 2026. doi:10.1039/d5dt02352a

BibTeX
@article{Ferrari2026,
  author = {Ferrari, Giulia and Lopez-Martinez, Ines and Saqawa, Mohamad and Demspey, Eithne and Wanek, Thomas and Pashkunova-Martic, Irena and Panseri, Silvia and Hacker, Marcus and Montesi, Monica and Kuntner, Claudia and Montagner, Diego},
  title = {68 Ga radiolabeling strategies in Pt( iv )-deferoxamine scaffolds for potential theranostic application},
  journal = {Dalton Transactions},
  year = {2026},
  doi = {10.1039/d5dt02352a}
}
Kostenlos starten →